Get Informed
The Disease
Alzheimer’s disease as a serious and prevalent condition has only been formally identified in recent history.
However, the disease itself has existed throughout human history. Our understanding of it is relatively recent:
- Over the past 100 years: Alzheimer’s disease was first formally described in 1906 by German physician
- Over the past 50 years: The international scientific community has made major advances in understanding the disease and its impacts. Ongoing research continues in the hope of discovering treatments and a cure.
- Over the past 20 years: Thanks in part to Alzheimer Societies around the world, significant efforts have been made to reduce stigma and better support individuals living with the disease, their families, and caregivers.
Much progress has been made, but there is still much work to do.
Learn more about the history of Alzheimer’s disease >>
Alzheimer’s disease is the most common neurocognitive disorder
Alzheimer’s disease accounts for 60% to 80% of all neurocognitive disorder diagnoses.
However, it is incorrect to assume that every neurocognitive disorder is Alzheimer’s disease, or that all neurocognitive disorders are forms of Alzheimer’s.
Learn the difference between Alzheimer’s disease and normal aging >>
Alzheimer’s disease changes brain function
It affects a person’s way of thinking, feeling, and acting.
Each person is affected differently. While symptoms and their progression can be unpredictable, there are early warning signs to watch for.
Learn more about the impact of Alzheimer’s on the brain >>
Alzheimer’s disease is progressive. Early diagnosis increases the chances of maintaining a better quality of life. It is important to speak openly with a family doctor or consult a specialist (such as a neurologist) when significant changes in daily functioning are noticed.
- Mild stage: Memory loss, difficulty learning new things, concentration issues, and mild coordination problems may appear. Symptoms become more frequent and affect familiar tasks. Early planning and support are recommended.
- Moderate stage: Cognitive decline becomes more noticeable. Assistance is needed for daily activities, and family involvement increases significantly. Community respite services may help, and specialized care housing may be considered.
- Advanced stage: The person is no longer able to communicate verbally or care for themselves. Basic functions such as eating and hygiene are affected, requiring full-time care.
- End of life: Cognitive decline reaches a stage where full-time care is required. Palliative and comfort care are provided to ensure quality of life.
IT’S POSSIBLE TO LIVE WELL WITH ALZHEIMER’S DISEASE
Although every journey is unique and challenging, it is possible to live well with Alzheimer’s or another major neurocognitive disorder.
Research shows that healthy lifestyle habits, physical activity, and cognitive stimulation can help slow progression and support adaptation to changes.
Resources and support are available for individuals and families. Early access to support can help maintain a good quality of life for as long as possible.
Find out what to do after a diagnosis >>
Key statistics (Alzheimer’s Disease International report, Sept. 21, 2022)
85% of people living with a neurocognitive disorder do not receive post-diagnostic support (medical, non-medical, home support, respite, and social inclusion services).
62% of healthcare professionals still consider neurocognitive disorders to be a normal part of aging.
59% of professionals report not having enough time to provide adequate support.
Get Informed
Research
As a member of the Quebec Alzheimer movement, the Alzheimer Society Laurentians (SAL) contributes to the collective effort of funding research initiatives, and more specifically to the promotion of the Alzheimer Society of Canada Research Program (ASRP).
This program has been in place since 1989. It brings together all provincial Alzheimer Society federations and helps fund projects while encouraging researchers to explore innovative and transformative approaches to advancing knowledge about neurocognitive disorders, with the goal of improving the quality of life of individuals living with these conditions, as well as their families and caregivers.
For the past two years, the ASRP has taken the form of an open competition structured around four key priorities: fundamental research, clinical research, health services, and population health.
Newsletter
Press Releases
Sainte-Agathe-des-Monts, June 2, 2025
On June 14, the Alzheimer Society Laurentides invites you to attend its 42nd Annual General Meeting, which will take place at the Centre Lafontaine located at 2020 Saint-Georges Street in Saint-Jérôme, as part of its 7th regional symposium.
…
Sainte-Agathe-des-Monts, June 19, 2025
The president and the executive director proudly shared the key results of the work carried out by the Alzheimer Society Laurentides (SAL) team over the past year.
…
Sainte-Agathe-des-Monts, June 18, 2025
On Sunday, May 25, the IG Wealth Management Walk for Alzheimer 2025 took place in the Laurentians region.
…
Documentation
The Alzheimer Society Laurentides has a Documentation Centre that is open to the public from Monday to Friday during regular business hours. Visitors will find pamphlets, brochures, books, and videos that help them better understand the various aspects of Alzheimer’s disease and major neurocognitive disorders, as well as the challenges faced by people living with the disease and their caregivers. Some materials are distributed free of charge, while others can be borrowed. A portion of the documentation is also available online.
To access these resources, click HERE!